Jay Hartenbach

President & COO at Diakonos Oncology

Speaker

Jay is a passionate advocate for wellness and innovative healthcare, bringing a unique blend of scientific knowledge, entrepreneurial enthusiasm, and business strategy expertise to the Life Sciences industry.

Jay is the President and COO at Diakonos Oncology, where the company is a recipient of FDA's Fast Track designation, Diakonos is a clinical-stage biotechnology company developing a groundbreaking Dendritic Cell Vaccine (DCV) for difficult-to-treat cancers.

In the past, Jay co-founded Medterra, a leading wellness company with international distribution. While his primary focus has shifted to biotech, he continues to shape Medterra’s strategic direction as Chairman of the Board. While at Medterra, Jay also co-founded Perland Pharmaceuticals, an early-stage biotech company actively developing therapies for arthritis conditions.

Instagram: Instagram.com/jhartenbach

Linkedin: Linkedin.com/jhartenbach

Twitter: twitter.com/jhartenbach

Education

Master’s in Engineering Management, Duke University

BS in Biomedical Engineering, University of Miami